{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:55:45Z","timestamp":1770753345733,"version":"3.50.0"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>During the COVID-19 pandemic, a significant increase in cases of mucormycosis was observed in COVID-19 patients, especially in India, but not exclusively. The presented cases highlight the heterogeneous nature of mucormycosis, emphasizing the importance of recognizing predisposing factors, such as immunosuppression, due to comorbidities or medication. Diagnosing mucormycosis poses a challenge due to nonspecific clinical manifestations, requiring a multidisciplinary approach for accurate diagnosis. Treatment involves a multi-pronged approach centered around the early initiation of antifungal therapy alongside surgical intervention and the management of underlying conditions, with an emphasis on controlling immunosuppression. Understanding the relationship between COVID-19 and predisposing factors for mucormycosis is fundamental for developing prevention and treatment strategies.<\/jats:p>","DOI":"10.3390\/jof10050305","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T03:56:31Z","timestamp":1713930991000},"page":"305","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Corona-Associated Mucormycosis: Case Series Reports and Review of the Literature"],"prefix":"10.3390","volume":"10","author":[{"given":"Andreea","family":"Fitero","sequence":"first","affiliation":[{"name":"Department of Psycho-Neuroscience and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0380-3381","authenticated-orcid":false,"given":"Nicoleta","family":"Negrut","sequence":"additional","affiliation":[{"name":"Department of Psycho-Neuroscience and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1423-4681","authenticated-orcid":false,"given":"Harrie Toms","family":"John","sequence":"additional","affiliation":[{"name":"Department of Ear, Nose and Throat, University Hospitals of Northamptonshire, Cliftonville, Northampton NN1 5BD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Ferician","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Marian","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"ref_1","unstructured":"(2024, January 12). Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/mucormycosis\/definition.html."},{"key":"ref_2","unstructured":"Hern\u00e1ndez, J.L., and Buckley, C.J. (2024). StatPearls, StatPearls Publishing LLC."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Alqarihi, A., Kontoyiannis, D.P., and Ibrahim, A.S. (2023). Mucormycosis in 2023: An update on pathogenesis and management. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1254919"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1093\/clinids\/14.Supplement_1.S126","article-title":"Mucormycosis","volume":"14","author":"Sugar","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Anand, T., Mukherjee, A., Satija, A., Velamuri, P.S., Singh, K.J., Das, M., Josten, K., Yadav, P.D., Sahay, R.R., and Keche, A.Y. (2022). A case control investigation of COVID-19 associated mucormycosis in India. BMC Infect. Dis., 22.","DOI":"10.21203\/rs.3.rs-1850369\/v1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100262","DOI":"10.1016\/j.omsc.2022.100262","article-title":"Resurgence of mucormycosis during COVID-19 pandemic","volume":"8","author":"Ali","year":"2022","journal-title":"Oral. Maxillofac. Surg. Cases"},{"key":"ref_7","unstructured":"Bhandari, J., Thada, P.K., and Nagalli, S. (2024). StatPearls, StatPearls Publishing LLC."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Popa, A., Chereji, A.-I., Dodu, M.A., Chereji, I., Fitero, A., Daina, C.M., Daina, L.G., Badau, D., Neculoiu, D.C., and Domnariu, C. (2022). The Impact of Changes regarding Working Circumstances during COVID-19 Pandemic upon Patients Evaluated for Thyroid Dysfunction. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19169856"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1571826","DOI":"10.1155\/2022\/1571826","article-title":"Comorbidities, Associated Diseases, and Risk Assessment in COVID-19-A Systematic Review","volume":"2022","author":"Fitero","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12223-021-00934-5","article-title":"Mucormycosis: Risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic","volume":"67","author":"Sharma","year":"2022","journal-title":"Folia Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Baldin, C., and Ibrahim, A.S. (2017). Molecular mechanisms of mucormycosis-The bitter and the sweet. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006408"},{"key":"ref_12","first-page":"e18827","article-title":"Risk of Mucormycosis in Diabetes Mellitus: A Systematic Review","volume":"13","author":"Khanna","year":"2021","journal-title":"Cureus"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2147\/IDR.S308176","article-title":"Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options","volume":"14","author":"Dessie","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3389\/fimmu.2020.01979","article-title":"Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections","volume":"11","author":"Sisson","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chandley, P., Subba, P., and Rohatgi, S. (2022). COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic. Vaccines, 10.","DOI":"10.3390\/vaccines10081266"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dogra, S., Arora, A., Aggarwal, A., Passi, G., Sharma, A., Singh, G., and Barnwal, R.P. (2021). Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.794176"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of Immune Response During SARS-CoV-2 Infec-tion: Lessons From the Past","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"864298","DOI":"10.3389\/fimmu.2022.864298","article-title":"CD8(+) T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives","volume":"13","author":"Mortezaee","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nicol\u00e1s, F.E., Murcia, L., Navarro, E., Navarro-Mendoza, M.I., P\u00e9rez-Arques, C., and Garre, V. (2020). Mucorales Species and Macrophages. J. Fungi, 6.","DOI":"10.3390\/jof6020094"},{"key":"ref_23","first-page":"504","article-title":"Mucormycosis in COVID-19: A systematic review of literature","volume":"29","author":"Nagalli","year":"2021","journal-title":"Infez. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/infdis\/150.5.752","article-title":"In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus","volume":"150","author":"Waldorf","year":"1984","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Aranjani, J.M., Manuel, A., Abdul Razack, H.I., and Mathew, S.T. (2021). COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic\u2019s second wave in India. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009921"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12281-023-00464-2","article-title":"Epidemiology of COVID-19-Associated Mucormycosis","volume":"17","author":"Tayabali","year":"2023","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Narros-Fern\u00e1ndez, P., Chomanahalli Basavarajappa, S., and Walsh, P.T. (2023). Interleukin-1 family cytokines at the crossroads of microbiome regulation in barrier health and disease. FEBS J.","DOI":"10.1111\/febs.16888"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12016-022-08928-y","article-title":"The Airway Microbiome-IL-17 Axis: A Critical Regulator of Chronic Inflammatory Disease","volume":"64","author":"Mannion","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India: Experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad. Med. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mhn.2002.126587","article-title":"Rhino-orbital and rhino-orbito-cerebral mucormycosis","volume":"127","author":"Talmi","year":"2002","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Moga, T.D., Nistor-Cseppento, C.D., Bungau, S.G., Tit, D.M., Sabau, A.M., Behl, T., Nechifor, A.C., Bungau, A.F., and Negrut, N. (2022). The Effects of the \u2018Catabolic Crisis\u2019 on Patients\u2019 Prolonged Immobility after COVID-19 Infection. Medicina, 58.","DOI":"10.3390\/medicina58060828"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-020-01561-x","article-title":"A challenging complication following SARS-CoV-2 infection: A case of pulmonary mucormycosis","volume":"49","author":"Pasero","year":"2021","journal-title":"Infection"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Nistor-Cseppento, C.D., Moga, T.D., Bungau, A.F., Tit, D.M., Negrut, N., Pasca, B., Bochis, C.F., Ghitea, T.C., Jurcau, A., and Purza, A.L. (2022). The Contribution of Diet Therapy and Probiotics in the Treatment of Sarcopenia Induced by Prolonged Immobilization Caused by the COVID-19 Pandemic. Nutrients, 14.","DOI":"10.3390\/nu14214701"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/01676830.2021.1903044","article-title":"Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19","volume":"41","author":"Dallalzadeh","year":"2022","journal-title":"Orbit"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J. Maxillofac. Oral Surg."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kanwar, A., Jordan, A., Olewiler, S., Wehberg, K., Cortes, M., and Jackson, B.R. (2021). A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19. J. Fungi, 7.","DOI":"10.3390\/jof7030174"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Negrut, N., Menegas, G., Kampioti, S., Bourelou, M., Kopanyi, F., Hassan, F.D., Asowed, A., Taleouine, F.Z., Ferician, A., and Marian, P. (2024). The Multisystem Impact of Long COVID: A Comprehensive Review. Diagnostics, 14.","DOI":"10.20944\/preprints202401.0099.v1"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1268840","DOI":"10.3389\/fmed.2023.1268840","article-title":"The outcome and the risk factors of mucormycosis among patients with hematological diseases: A systematic and meta-analysis","volume":"10","author":"Shen","year":"2023","journal-title":"Front. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mare\u0219, M., Moroti-Constantinescu, V.R., and Denning, D.W. (2018). The Burden of Fungal Diseases in Romania. J. Fungi, 4.","DOI":"10.20944\/preprints201802.0137.v1"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3892\/etm.2021.11000","article-title":"Endoscopic assessment of sinonasal mucormycosis with SPIES: The \u2018battlefield\u2019 sign","volume":"23","author":"Zainea","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_44","first-page":"9","article-title":"A rare case of knee joint mucormycosis with pathological fracture after COVID-19 infection","volume":"4","author":"Iordache","year":"2021","journal-title":"Rom. J. Orthop. Surg. Traumatol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Mahler, B., Parliteanu, O.A., Alexe, O., R\u00ee\u0219c\u0103 Popazu, C., Ene, C.E., Timar, B., and Constantinescu, T. (2023). Mucormycosis in a Patient with Severe COVID-19 Disease-The First Case Report in Romania and a Literature Review. Medicina, 59.","DOI":"10.3390\/medicina59030555"},{"key":"ref_46","first-page":"47","article-title":"A case of mucormycosis causing acute pansinusitis with periorbital involvement in a severe case of COVID-19 pneumonia","volume":"14","author":"Crisan","year":"2022","journal-title":"HVM Bioflux"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/5\/305\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:00Z","timestamp":1760106780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/5\/305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["jof10050305"],"URL":"https:\/\/doi.org\/10.3390\/jof10050305","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]}}}